The impact of smoking on TB treatment outcomes includes recurrent TB

Int J Tuberc Lung Dis. 2020 Nov 1;24(11):1224-1225. doi: 10.5588/ijtld.20.0411.

Authors

C-Y Chiang¹, T S Bam²

Affiliations

¹ International Union Against Tuberculosis and Lung Disease, Paris, France, Division of Pulmonary Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, <email></email>, Email: cychiang@theunion.org.
² International Union Against Tuberculosis and Lung Disease, Paris, France.

PMID: 33172536
DOI: 10.5588/ijtld.20.0411

No abstract available

Publication types

Letter
Comment

MeSH terms

Antitubercular Agents / therapeutic use
Humans
Smoking* / adverse effects
Treatment Outcome
Tuberculosis* / drug therapy
Tuberculosis* / epidemiology

Substances

Antitubercular Agents